APAC Spatial Genomics & Transcriptomics Market

[134 Pages Report] The Asia Pacific spatial genomics & transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period. The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are the increasing capital investments, rising use of spatial omics for disease diagnosis, and rising rate in the adoption rate of spatial genomics and transcriptomics in drug discovery & development. However, analytical limitation associated with spatial techniques are expected to restrain market growth to a certain extent.

Attractive Opportunities in the Asia Pacific Spatial Genomics & Transcriptomics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Asia Pacific Spatial Genomics & Transcriptomics Market Dynamics

DRIVER: Reduced cost of next-generation sequencing

The cost of next-generation sequencing (NGS) is continuing to decline, with Illumina leading the way in making NGS more affordable and accessible. This is expected to create a robust customer base as laboratories of all sizes are now able to adopt NGS. In October 2022, Illumina launched the NovaSeqX series, a quicker and cheaper genomic sequencing platform, in Thailand. The new platform is a significant improvement over the previous models in terms of speed and cost. The NovaSeqX series is expected to minimize the cost of genome sequencing to just USD 200–300 per sample (this excludes costs associated with processing, interpretation, and counseling), down from USD 600. The new platform delivers more than 20,000 whole genomes of high-resolution optics and ultra-high density flow cells per year, which is 2.5 times greater throughput than the previous model. Such developments are expected to increase the accessibility of NGS across Asia Pacific countries, which would expand its applications in the spatial genomics and transcriptomics market.

CHALLENGES: Analytical limitations associated with spatial techniques

The key analytical limitation associated with spatial genomics and transcriptomics is the limited number of genes that can be analyzed in one go. A variety of methods have been commercialized by market players to visualize mRNA sequences on tissue sections. However, the maximum number of different genes that can be analyzed at a time with such techniques is limited. Customers make use of quantitative and sensitive spatial transcriptomic sequencing methods, but only 3 to 4 genes can be analyzed at once. This creates a challenging environment for customers looking to adopt spatial transcriptomics and genomics techniques.

The Spatial Transcriptomics accounted for the largest share of the technique segments in spatial genomics & transcriptomics market in 2022.

Based on technique, the market is categorized into spatial transcriptomics, and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for the largest share of the spatial genomics and transcriptomics market. Increasing demand for and high adoption rate of in situ sequencing techniques is expected to drive the growth of the spatial transcriptomics segment during the forecast period.

The Consumables segment dominated the product segment in spatial genomics & transcriptomics market in 2021.

Based on the product, the segment is categorized into consumables, instruments and software. In 2021, the consumables segment dominated the product segment with the highest revenue share. Growing use of consumables for various spatial genomics and transcriptomics applications is estimated to drive the market growth.

In 2021, the translational research segment have generated highest revenue in the application segment for spatial genomics & transcriptomics market.

Based on the application, the Asia Pacific Spatial Genomics & Transcriptomics Market is segmented into translational research, and drug discovery & development. In 2022, the translational research have generated highest revenue in the application segment. The large share of the translational research segment can be attributed to the increasing use of spatial genomics and transcriptomics to determine high-throughput data on the organizational structure of cell content from tissue and cell species.

China was the largest market for Asia Pacific Spatial Genomics & Transcriptomics in 2022.

Geographically, the spatial genomics & transcriptomics market is segmented into Japan, China, India and Rest of Asia Pacific. The spatial genomics & transcriptomics market is dominated by China in 2022 and this dominance is anticipated to continue throughout the forecast period. The large share of the segment can be attributed to the rising incidence of chronic diseases and technological advancements and the launch of cell therapies to treat different cancers in the spatial genomics and transcriptomics market in this region.

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Prominent players in the spatial genomics & transcriptomics market include NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), S2 Genomics (US), Cantata Bio (US), Vizgen Group (US), BGI Group (China), Miltenyi Biotec (Germany), Bruker (US), Perkinelmer Inc. (US), and Novogene Co., Ltd. (China).

Want to explore hidden markets that can drive new revenue in APAC Spatial Genomics & Transcriptomics Market?

Unlock Insights

Click on image to enlarge

Scope of the Report

This report categorizes the Asia Pacific spatial genomics & transcriptomics market into the following segments:

Asia Pacific Spatial Genomics & Transcriptomics Market, by Technique

• Spatial Transcriptomics
• Immunohistochemistry (IHC)
• In Situ Hybridization
• Sequencing Techniques
• Microscopy based RNA imaging
• Other Spatial Transcriptomics Techniques
• Spatial Genomics Analysis
• Immunohistochemistry (IHC)
• In Situ Hybridization
• Sequencing Techniques
• Microscopy based RNA imaging
• Other Spatial Transcriptomics Techniques

Asia Pacific Spatial Genomics & Transcriptomics Market, by Product

• Instruments
• Consumables
• Software

Asia Pacific Spatial Genomics & Transcriptomics Market, by Application

• Translational Research
• Drug Discovery and Development

Asia Pacific Spatial Genomics & Transcriptomics Market, by End User

• Academic and Research Institutes
• Contract Research Organization
• Pharmaceutical and Biotechnology Companies

Asia Pacific Spatial genomics & transcriptomics Market, by Country

• Asia Pacific (APAC)
  • Japan
  • India
  • China
  • Rest of Asia Pacific (RoAPAC)

Recent Developments

• In 2022, NanoString and Abcam announced an agreement to co-market Abcam antibodies for NanoString’s high-plex spatial multiomics solutions.
• In 2022, 10x Genomics announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling of genes and proteins at subcellular resolution.
• In 2022, Illumina and AstraZeneca announced a strategic research collaboration to accelerate drug target discovery by combining their strengths in AI-based genome interpretation and genomic analysis techniques with industry expertise.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst